Table 2 Key targets.

From: Studying the efficacy of JBOL volatile components in idiopathic pulmonary fibrosis (IPF) using GC-MS and network pharmacology

Betweenness unDir

Closeness unDir

Degree unDir

Name

1187.158186

0.003649635

55

STAT3

1947.953742

0.003846154

55

EGFR

2323.451963

0.003759398

54

SRC

1292.475985

0.003759398

51

AKT1

1808.688347

0.003636364

47

IL-1β

1932.254862

0.003546099

44

HSP90AA1

1400.472129

0.003610108

41

MMP9

626.2661552

0.003424658

38

JAK2

1358.850919

0.003546099

38

TLR4

545.1428951

0.003533569

36

BCL2

253.7318472

0.003344482

34

STAT1

394.2484599

0.003311258

31

NFKB1

511.7494714

0.003344482

31

CASP3

1048.09662

0.003472222

31

ESR1

1919.919728

0.003389831

29

ALB

538.0787277

0.003322259

29

IGF1

441.9756783

0.003115265

27

MAPK1

1140.195957

0.003378378

26

PTGS2

322.8152953

0.003236246

25

ICAM1

340.4391118

0.003257329

23

MAPK8

260.7333828

0.003246753

22

MMP2

521.3635859

0.003076923

21

SERPINE1

529.7371289

0.003067485

15

NOS3

565.4442779

0.002777778

14

ACE